The Basic Problems And Proposal In The Development Of Jilin Province Zhongxi Pharmaceutical

Jilin Province, Zhongxi Pharmaceutical Company which includes research,industry and trade is one of the group company. The nineties of last century, Zhongxi pharmaceutical company in Jilin Province at an surprising speed of development and great achievements had become professional milestone. However, since 2001, after the establishment of industrial enterprises, especially in recent years, the pace of development was slow up and was always in middle and lower status,had lost the aura and status of the industry. It's Time to find out the reasons that the enterprise got behind and analyze its cause and put forward feasible suggestions .It's very important to help Zongxi Pharmaceutical Company to break away the predicament and reproduce the past brilliant, but also for the development of the industry the way other companies to provide a reference.Firstly, according to marketing and strategic management theory, adopting qualitative analysis and quantitative analysis, applying deductive and inductive methods, I analyze its human Resources ,product mix, marketing models, marketing status, market conditions, competitor status deeply for enterprise development to identify the problem lay in the foreshadowing.Secondly,Ⅰanalyze the actual status of Jilin Province and Zhongxin pharmaceutical Company to complete the second five-year development plan situation,Ⅰsummarize some salient problems during the development of Jilin Province, Zhongxi Pharmaceutical Company, about company decision-making mechanism, talent introduction and use of strategy, product positioning and the main introduction of strategies and management methods and style of corporate managers more prominent problems exist. Embodied in the corporate transformation, failed to timely introduction of Zhongxi pharmaceutical Company and business strategy development and reuse of talent to match, but over-reliance and esteem the original entrepreneur; variety of research and development and the introduction of few bright spots has always been, not in the market on the "final word" species become the dominant factor in the slow sales growth; management is too humane, "state-owned complex" serious lack of results of the task targets the implementation of assessment and reward and punishment, affecting staff motivation and innovation play and contributes to the inertia.Again, I perceive the causes of their problems according to analyzing this capital structure of Jilin Zhongxi Pharmaceutical Company, policy makers and corporate decision-making way of thinking, the company leadership structure and mentality, the mentality of corporate middle managers for the proposed future of Jilin Province lay the foundation for development proposals.Finally, according to the above analysis combined with the actual status of Jilin Province Zhongxi Pharmaceutical Company, I propos the following recommendations:(Ⅰ) positions to the existing management to make the necessary updates, re-positioning of personnel management; establishment of internal sound personnel selection and competition, changes in genetics; timely introduction of modern industrial enterprises for the development of high-end R & D and sales personnel, and entrusted with the reuse of the phase of the outstanding equity incentives are. (Ⅱ)set of cooperative R & D strength of the whole company or the introduction of a high-end products with independent intellectual property rights, thoroughly improved product structure, improve product quality.(Ⅲ) of existing management and style phoenix-like transformation to adapt to the rapid development of modern enterprises, serious reward and punishment system and indicators assessment. (Ⅳ) when the time comes, the marriage of large enterprises, so that corporate brand and increase comprehensive strength to jump. Development proposals more than willing to help out of the woods in Jilin Province Zhongxi Pharmaceutical Company as soon as possible, to reproduce the old style, to revitalize the local economy and medicine to make due contributions to the health of the people.